Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trial Database Endorsed By PhRMA; Proposal Coming Soon

Executive Summary

The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products

You may also be interested in...



PhRMA Clinical Trials Registry To Be Launched Oct. 1

The Pharmaceutical Research & Manufacturers of America will seek a third party to operate an industry database of clinical trial results

Paxil Settlement Requires Disclosure Of Early Phase Research

The Paxil settlement between GlaxoSmithKline and New York Attorney General Eliot Spitzer sets a standard for clinical trial disclosure that goes beyond the position taken by the Pharmaceutical Research & Manufacturers of America

Paxil Settlement Requires Disclosure Of Early Phase Research

The Paxil settlement between GlaxoSmithKline and New York Attorney General Eliot Spitzer sets a standard for clinical trial disclosure that goes beyond the position taken by the Pharmaceutical Research & Manufacturers of America

Related Content

Topics

UsernamePublicRestriction

Register

PS044497

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel